MorphoSys AG (MOR) Social Stream



MorphoSys AG (MOR): $18.63

0.20 (+1.09%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

MORPHOSYS AG (MOR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MOR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 3 $26 $16 $21.333 $9.41 126.71%
2021-11-12 3 $25 $16 $21 $9.41 123.17%
2022-01-04 3 $25 $11 $19.333 $9.41 105.45%
2022-03-21 2 $22 $11 $16.5 $9.41 75.35%
2022-04-04 2 $11 $11 $11 $9.41 16.9%
2022-05-11 2 $11 $9 $10 $9.41 6.27%
2022-05-20 2 $10 $9 $9.5 $9.41 0.96%
2022-06-24 2 $9 $7 $8 $9.41 -14.98%
2022-08-04 2 $9 $7.1 $8.05 $9.41 -14.45%
2022-08-10 4 $8.3 $7.1 $7.7 $9.41 -18.17%
2022-11-18 5 $15 $5 $9.033 $9.41 -4.01%
2022-11-21 6 $15 $4.5 $8.166 $9.41 -13.22%
2023-01-03 6 $15 $2.9 $7.466 $9.41 -20.66%
2023-04-26 6 $15 $2.9 $7.033 $9.41 -25.26%
2023-05-08 6 $15 $2.9 $7.133 $9.41 -24.2%
2023-05-18 6 $15 $3.3 $7.266 $9.41 -22.78%
2023-06-16 7 $17 $3.5 $11.375 $9.41 20.88%
2023-08-10 8 $17 $3.5 $11.375 $9.41 20.88%
2023-08-17 8 $17 $3.7 $11.425 $9.41 21.41%
2023-09-25 8 $17 $3.7 $10.99 $9.41 16.79%
2023-10-13 8 $17 $9.2 $11.362 $9.41 20.74%
2023-11-21 8 $17 $9.2 $12.49 $9.41 32.73%
2023-11-22 8 $17 $4.75 $11.59 $9.41 23.17%
2023-12-05 8 $17 $4.75 $11.29 $9.41 19.98%

The Trend in the Analyst Price Target


Over the past 19 months, MOR's average price target has gone up $1.29.

Over the past 48 weeks, MOR's average upside potential has been 58.49%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-26 6 15 2.9 7.033 5.16 36.3%
2023-06-16 7 15 3.5 9.500 7.72 23.06%
2023-06-16 7 17 3.5 11.375 7.72 47.34%
2023-10-13 8 17 9.2 11.362 6.50 74.8%
2023-11-21 8 17 9.2 12.490 4.55 174.51%

MOR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.06 4 1 2 1 1 8

The Trend in the Broker Recommendations


Over the past 31 weeks, MOR's average broker recommendation rating improved by 2.21.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how MORPHOSYS AG fares relative to all US stocks, note that its average analyst price target is higher than 384.34% of that group.
  • MOR has a lower variance in analysts' estimates than -1974.8% of all US stocks.
  • MORPHOSYS AG's upside potential (average analyst target price relative to current price) is higher than 592.64% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, MORPHOSYS AG's number of analysts covering the stock is higher than 865.86% of them.

Stocks similar to MORPHOSYS AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RCUS, ZYME, and HCM.

What is the outlook for MOR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!